Previous evidence exhibited that a high expression of TGFB1 may have a worse prognosis by recruiting vasculature, reinforcing invasiveness and metastasis, and highlighting the significance of TGFB1 as a potential immunotherapeutic target of immune checkpoint blockade for rectal cancer [48, 49]. This evidence concerns the gene TGFB1 and rectal cancer.